In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Thermo Fisher Scientific Inc (NYSE: TMO) closed at $392.56 up 0.59% from its previous closing price of $390.26. In other words, the price has increased by $0.59 from its previous closing price. On the day, 2.88 million shares were traded. TMO stock price reached its highest trading level at $395.78 during the session, while it also had its lowest trading level at $385.46.
Ratios:
For a deeper understanding of Thermo Fisher Scientific Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 24.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.04. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.77. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.64.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 12 ’25 when Pettiti Gianluca sold 400 shares for $411.11 per share. The transaction valued at 164,444 led to the insider holds 22,767 shares of the business.
Pettiti Gianluca bought 400 shares of TMO for $164,444 on May 12 ’25. On Apr 28 ’25, another insider, Pettiti Gianluca, who serves as the Executive Vice President of the company, sold 300 shares for $429.93 each. As a result, the insider received 128,979 and left with 23,167 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMO now has a Market Capitalization of 148189052928 and an Enterprise Value of 176596008960. As of this moment, Thermo’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.04, and their Forward P/E ratio for the next fiscal year is 15.90. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.87. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.45 while its Price-to-Book (P/B) ratio in mrq is 3.00. Its current Enterprise Value per Revenue stands at 4.117 whereas that against EBITDA is 16.312.
Stock Price History:
The Beta on a monthly basis for TMO is 0.78, which has changed by -0.29549003 over the last 52 weeks, in comparison to a change of 0.092761636 over the same period for the S&P500. Over the past 52 weeks, TMO has reached a high of $627.88, while it has fallen to a 52-week low of $389.86. The 50-Day Moving Average of the stock is -5.48%, while the 200-Day Moving Average is calculated to be -24.25%.
Shares Statistics:
For the past three months, TMO has traded an average of 2.62M shares per day and 2528470 over the past ten days. A total of 377.49M shares are outstanding, with a floating share count of 376.78M. Insiders hold about 0.19% of the company’s shares, while institutions hold 91.32% stake in the company. Shares short for TMO as of 1748563200 were 4738620 with a Short Ratio of 1.81, compared to 1745971200 on 4537399. Therefore, it implies a Short% of Shares Outstanding of 4738620 and a Short% of Float of 1.26.
Dividends & Splits
According to the company, the forward annual dividend rate for TMO is 1.64, from 1.6 in the trailing year. Against a Trailing Annual Dividend Yield of 0.004099831The stock’s 5-year Average Dividend Yield is 0.23. The current Payout Ratio is 9.43% for TMO, which recently paid a dividend on 2025-06-13 with an ex-dividend date of 1749772800. Stock splits for the company last occurred on 1996-06-06 when the company split stock in a 3:2 ratio.
Earnings Estimates
At present, 22.0 analysts are actively evaluating the performance of Thermo Fisher Scientific Inc (TMO) in the stock market.The consensus estimate for the next quarter is $5.55, with high estimates of $5.82 and low estimates of $5.34.
Analysts are recommending an EPS of between $24.58 and $22.0 for the fiscal current year, implying an average EPS of $22.46. EPS for the following year is $24.81, with 28.0 analysts recommending between $27.18 and $23.5.
Revenue Estimates
A total of 20 analysts believe the company’s revenue will be $10.68B this quarter.It ranges from a high estimate of $10.75B to a low estimate of $10.49B. As of the current estimate, Thermo Fisher Scientific Inc’s year-ago sales were $10.54BFor the next quarter, 20 analysts are estimating revenue of $10.84B. There is a high estimate of $10.98B for the next quarter, whereas the lowest estimate is $10.71B.
A total of 27 analysts have provided revenue estimates for TMO’s current fiscal year. The highest revenue estimate was $44.11B, while the lowest revenue estimate was $43.36B, resulting in an average revenue estimate of $43.7B. In the same quarter a year ago, actual revenue was $42.88BBased on 27 analysts’ estimates, the company’s revenue will be $46.41B in the next fiscal year. The high estimate is $48.04B and the low estimate is $45.01B.
